Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Molecular Cancer Therapeutics|January 5, 2013
A second-generation 2-Methoxyestradiol prodrug is effective against Barrett's adenocarcinoma in a mouse xenograft modelSuman Kambhampati, Roger A Rajewski, Mehmet Tanol, et al.
The Journal of Biological Chemistry|February 8, 2018
The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signalingGargi Maity, Inamul Haque, Arnab Ghosh, et al.
Molecular Pharmaceutics|November 5, 2020
Chemical Architecture of Block Copolymers Differentially Abrogate Cardiotoxicity and Maintain the Anticancer Efficacy of DoxorubicinChowdhury S Abdullah, Priyanka Ray, Shafiul Alam, et al.
Research Square|June 5, 2025
Targeted Nanoencapsulation of Tunicamycin Reduces Toxicity While Improving its Therapeutic Effectiveness in Pancreatic Cancer CellsDebasmita Dutta, Sunil Upadhyay, Archana De, et al.
Molecular Therapy. Oncology|October 2, 2025
Targeted nanoencapsulation of tunicamycin reduces toxicity while improving its therapeutic effectiveness in pancreatic cancer cellsDebasmita Dutta, Sunil P Upadhyay, Archana De, et al.
Molecular Cancer Therapeutics|February 22, 2019
CYR61/CCN1 Regulates dCK and CTGF and Causes Gemcitabine-resistant Phenotype in Pancreatic Ductal AdenocarcinomaGargi Maity, Arnab Ghosh, Vijayalaxmi Gupta, et al.
Molecular Pharmaceutics|November 24, 2020
pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth in Pancreatic CancerPriyanka Ray, Debasmita Dutta, Inamul Haque, et al.
The Journal of Biological Chemistry|March 3, 2019
A novel triazole, NMK-T-057, induces autophagic cell death in breast cancer cells by inhibiting γ-secretase-mediated activation of Notch signalingAmlan Das, Maruthi Kumar Narayanam, Santanu Paul, et al.
Pageof 8